Commentary: Drug companies must report clinical trial results, even when they won't lead to a product

Drug companies sponsoring human trials of possible new medications have ethical responsibilities to study participants and to science to disclose the results of their clinical research -- even when product development is no longer being pursued, says a commentary co-authored by a leading UC Davis drug researcher published online today in Science Translational Medicine.

Read the whole article on Physorg

More from Physorg